Clinical Trials Directory

Trials / Completed

CompletedNCT01434277

Safety Evaluation of a New Preservative in a Lubricating Eye Drop

A Single-Center Study Evaluating the Safety of a New Preservative in an OTC Lubricant Eye Drop Used QID in Healthy Adults and in Subjects Diagnosed With Dry Eye

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Johnson & Johnson Consumer and Personal Products Worldwide · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is to evaluate the safety of a new preservative in a lubricant eye drop used four times a day in healthy adults and subjects diagnosed with dry eye.

Detailed description

Single-site, open-labeled study. Twenty two subjects will be enrolled into the healthy adult group and twenty two subjects into the dry eye group. Each subject will be in the study for approximately 2 weeks (treatment) and seen at three study Visits: Visit 1 (Day 0, Baseline), Visit 2 (Day 7 +/- 1) and Visit 3 (Day 14 +/- 1). Dosing regimen is 1-2 drops into each eye, four times daily, for two weeks. Assessments will be comprised of visual acuity, slit lamp biomicroscopy, fluorescein corneal staining, and product comfort.

Conditions

Interventions

TypeNameDescription
OTHEREye Drops with Experimental PreservativeGlycerin, Hypromellose, Polyethylene glycol 400 with experimental preservative PQ-42

Timeline

Start date
2011-04-01
Primary completion
2011-04-01
Completion
2011-04-01
First posted
2011-09-14
Last updated
2011-09-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01434277. Inclusion in this directory is not an endorsement.